A virulent parent with probiotic progeny: Comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972

Molecular Genetics and Genomics

Volumn 283, Issue 5, 2010, Pages 469-484

  Vejborg, Rebecca Munk ^a   Friis, Carsten ^a   Hancock, Viktoria ^a   Schembri, Mark A ^b   Klemm, Per ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ABU 83972; CFT073; Comparative genomic hybridization analysis; Escherichia coli; Nissle 1917; Urinary tract infection

Indexed keywords

BACTERIAL PROTEIN; VIRULENCE FACTOR; PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COMMENSAL; COMPARATIVE GENOMIC HYBRIDIZATION; ESCHERICHIA COLI; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; BACTERIAL GENE; CLUSTER ANALYSIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; GENOMIC ISLAND; GENOMICS; METABOLISM; PATHOGENICITY; PHENOTYPE; PROPHAGE; REPRODUCIBILITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENETIC VARIATION; GENOMIC ISLANDS; GENOMICS; PHENOTYPE; PROBIOTICS; PROPHAGES; REPRODUCIBILITY OF RESULTS; VIRULENCE FACTORS;

EID: 77951629208     PISSN: 16174615     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00438-010-0532-9     Document Type: Article

References (66)

1. Alteri CJ, Mobley HL (2007) Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun 75(6):2679-2688
2. Andersson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S, Svanborg C (1991) Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 59:2915-2921
3. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL (2008) GenBank. Nucleic Acids Res 36:D25-D30
4. Bhargava S, Johnson BB, Hwang J, Harris TA, George AS, Muir A, Dorff J, Okeke IN (2009) Heat-resistant agglutinin 1 is an accessory enteroaggregative Escherichia coli colonization factor. J Bacteriol 191:4934-4942
5. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, Sabo A, Blasiar D, Bieri T, Meyer RR, Ozersky P, Armstrong JR, Fulton RS, Latreille JP, Spieth J, Hooton TM, Mardis ER, Hultgren SJ, Gordon JI (2006) Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli a comparative genomics approach. Proc Natl Acad Sci USA 103:5977-5982
6. Chouikha I, Germon P, Bree A, Gilot P, Moulin-Schouleur M, Schouler C (2006) A selC-associated genomic island of the extraintestinal avian pathogenic Escherichia coli strain BEN2908 is involved in carbohydrate uptake and virulence. J Bacteriol 188:977-987
7. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, Svanborg C, Miethke T (2008) Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14:399-406
8. Connell H, Agace W, Klemm P, Schembri M, Marild S, Svanborg C (1996) Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 93:9827-9832
9. Croxen MA, Finlay BB (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8:26-38
10. Danese PN, Pratt LA, Dove SL, Kolter R (2000) The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol 37:424-432
11. Dobrindt U, Hentschel U, Kaper JB, Hacker J (2002) Genome plasticity in pathogenic and nonpathogenic enterobacteria. Curr Top Microbiol Immunol 264:157-175
12. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
13. Gottesman S, Stout V (1991) Regulation of capsular polysaccharide synthesis in Escherichia coli K12. Mol Microbiol 5:1599-1606
14. Grozdanov L, Zahringer U, Blum-Oehler G, Brade L, Henne A, Knirel YA, Schombel U, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, Rietschel ET, Dobrindt U (2002) A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol 184:5912-5925
15. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, Dobrindt U (2004) Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186:5432-5441
16. Hacker J, Carniel E (2001) Ecological fitness, genomic islands and bacterial pathogenicity. A Darwinian view of the evolution of microbes. EMBO Rep 2:376-381
17. Hafez M, Hayes K, Goldrick M, Warhurst G, Grencis R, Roberts IS (2009) The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction. Infect Immun 77:2995-3003
18. Hagan EC, Mobley HL (2007) Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 75:3941-3949
19. Hancock V, Klemm P (2007) Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urine. Infect Immun 75:966-976
20. Hancock V, Ferrieres L, Klemm P (2007) Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiol Lett 267:30-37
21. Hancock V, Seshasayee AS, Ussery DW, Luscombe NM, Klemm P (2008) Transcriptomics and adaptive genomics of the asymptomatic bacteriuria Escherichia coli strain 83972. Mol Genet Genomics 279:523-534
22. Hancock V, Nielsen EM, Krag L, Engberg J, Klemm P (2009) Comparative analysis of antibiotic resistance and phylogenetic group patterns in human and porcine urinary tract infectious Escherichia coli. APMIS 117:786-790
23. Hannan TJ, Mysorekar IU, Chen SL, Walker JN, Jones JM, Pinkner JS, Hultgren SJ, Seed PC (2008) LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol Microbiol 67:116-128
24. Hentschel U, Hacker J (2001) Pathogenicity islands: the tip of the iceberg. Microbes Infect 3:545-548
25. Hobohm U, Scharf M, Schneider R, Sander C (1992) Selection of representative protein data sets. Protein Sci 1:409-417
26. Hull RA, Rudy DC, Donovan WH, Wieser IE, Stewart C, Darouiche RO (1999) Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 67:429-432
27. Hull R, Rudy D, Donovan W, Svanborg C, Wieser I, Stewart C, Darouiche R (2000) Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol 163:872-877
28. Johanson IM, Plos K, Marklund BI, Svanborg C (1993) Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microb Pathog 15:121-129
29. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123-140
30. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA (2006) Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 74:781-785
31. Klemm P, Hancock V, Schembri MA (2007) Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun 75:3688-3695
32. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853-858
33. Lane MC, Mobley HL (2007) Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int 72:19-25
34. Larsen TS, Krogh A (2003) EasyGene-a prokaryotic gene finder that ranks ORFs by statistical significance. BMC Bioinformatics 4:21
35. Lindberg U, Hanson LA, Jodal U, Lidin-Janson G, Lincoln K, Olling S (1975) Asymptomatic bacteriuria in schoolgirls. II. Differences in Escherichia coli causing asymptomatic bacteriuria. II. Differences in Escherichia coli causing asymptomatic bacteriuria. Acta Paediatr Scand 64:432-436
36. Lloyd AL, Rasko DA, Mobley HL (2007) Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 189:3532-3546
37. Lloyd AL, Henderson TA, Vigil PD, Mobley HL (2009) Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol 191:3469-3481
38. Malchow HA (1997) Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 25:653-658
39. Middendorf B, Hochhut B, Leipold K, Dobrindt U, Blum-Oehler G, Hacker J (2004) Instability of pathogenicity islands in uropathogenic Escherichia coli 536. J Bacteriol 186:3086-3096
40. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell CV, Jones BD, Warren JW (1990) Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58:1281-1289
41. Monteiro C, Saxena I, Wang X, Kader A, Bokranz W, Simm R, Nobles D, Chromek M, Brauner A, Brown RM Jr, Romling U (2009) Characterization of cellulose production in Escherichia coli Nissle 1917 and its biological consequences. Environ Microbiol 11:1105-1116
42. Nielsen P, Krogh A (2005) Large-scale prokaryotic gene prediction and comparison to genome annotation. Bioinformatics 21:4322-4329
43. Nissle A (1918) Die antagonistische Behandlungen chronischer Darmstörungen mir Kolibakterien. Med Klein 2:29-30
44. Nissle A (1925) Weiteres über Grundlagen und Praxis der Mutaflorbehandlung. DMW 4:1809-1813
45. Prigent-Combaret C, Prensier G, Le Thi TT, Vidal O, Lejeune P, Dorel C (2000) Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ Microbiol 2:450-464
46. Roos V, Klemm P (2006) Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun 74:3565-3575
47. Roos V, Ulett GC, Schembri MA, Klemm P (2006) The asymptomatic bacteriuria Escherichia coli strain 83972 out-competes UPEC strains in human urine. Infect Immun 74:615-624
48. Russo TA, Carlino UB, Johnson JR (2001) Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 69:6209-6216
49. Schultz M (2008) Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis 14:1012-1018
50. Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, Welch RA, Mobley HL (2004) Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72:6373-6381
51. Sonnenborn U, Schulze J (2009) The non-pathogenic Escherichia coli strain Nissle 1917-features of a versatile probiotic. Microb Ecol Health Dis 21:122-158
52. Stamm WE (1991) Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 91:65S-71S
53. Stapleton A, Moseley S, Stamm WE (1991) Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. J Infect Dis 163:773-779
54. Stout V, Torres-Cabassa A, Maurizi MR, Gutnick D, Gottesman S (1991) RcsA, an unstable positive regulator of capsular polysaccharide synthesis. J Bacteriol 173:1738-1747
55. Sun J, Gunzer F, Westendorf AM, Buer J, Scharfe M, Jarek M, Gossling F, Blocker H, Zeng AP (2005) Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. J Biotechnol 117:147-161
56. Sunden F, Hakansson L, Ljunggren E, Wullt B (2006) Bacterial interference-is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection? Int J Antimicrob Agents 28(Suppl 1):S26-S29
57. Tischler AD, Camilli A (2004) Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol Microbiol 53:857-869
58. Tischler AD, Camilli A (2005) Cyclic diguanylate regulates Vibrio cholerae virulence gene expression. Infect Immun 73:5873-5882
59. Tseng CC, Huang JJ, Wang MC, Wu AB, Ko WC, Chen WC, Wu JJ (2007) PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int 71:764-770
60. Vejborg RM, Bernbom N, Gram L, Klemm P (2008) Anti-adhesive properties of fish tropomyosins. J Appl Microbiol 105:141-150
61. Vianney A, Jubelin G, Renault S, Dorel C, Lejeune P, Lazzaroni JC (2005) Escherichia coli tol and rcs genes participate in the complex network affecting curli synthesis. Microbiology 151:2487-2497
62. von Bargen K, Polidori M, Becken U, Huth G, Prescott JF, Haas A (2009) Rhodococcus equi virulence-associated protein A is required for diversion of phagosome biogenesis but not for cytotoxicity. Infect Immun 77:5676-5681
63. Welch RA, Burland V, Plunkett G 3rd, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mobley HL, Donnenberg MS, Blattner FR (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 99:17020-17024
64. Wernersson R, Nielsen HB (2005) OligoWiz 2.0-integrating sequence feature annotation into the design of microarray probes. Nucleic Acids Res 33:W611-W615
65. Wernersson R, Juncker AS, Nielsen HB (2007) Probe selection for DNA microarrays using OligoWiz. Nat Protoc 2:2677-2691
66. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U (2008) Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 76:695-703